Ron Cohen's Insider Trades & SAST Disclosures

Ron Cohen's most recent trade in Acorda Therapeutics Inc was a trade of 168,800 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 31, 2023.

Share

Note

This is a custom search result for pattern Ron Cohen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Acorda Therapeutics Inc 10-year low	Ron Cohen	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Mar 2023	168,800	168,800	-		-	Employee Stock Option (right to buy)
Acorda Therapeutics Inc 10-year low	Ron Cohen	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 0.60 per share.	16 Mar 2023	10,156	139,757 (0%)	0%	0.6	6,094	Common Stock
Acorda Therapeutics Inc 10-year low	Ron Cohen	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 0.65 per share.	16 Mar 2023	10,000	149,757 (0%)	0%	0.7	6,500	Common Stock
Acorda Therapeutics Inc 10-year low	Ron Cohen	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 1.70 per share.	17 Mar 2022	2,289	129,601 (0%)	0%	1.7	3,895	Common Stock
Acorda Therapeutics Inc 10-year low	Ron Cohen	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Nov 2021	100,000	100,000	-		-	Employee Stock Option (right to buy)
Acorda Therapeutics Inc 10-year low	Ron Cohen	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.38 per share.	03 Sep 2021	3,940	131,890 (0%)	0%	4.4	17,257	Common Stock
Acorda Therapeutics Inc 10-year low	Ron Cohen	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2021	29,000	135,830 (0%)	0%		0	Common Stock
Acorda Therapeutics Inc 10-year low	Ron Cohen	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Sep 2020	8,543	640,980 (1%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades